Read on Twitter
Time for this weeks top highlights from TCTMD!
Lotus Edge TAVR Device Recalled and Discontinued Worldwide https://bit.ly/2IWhpKg
Boston Scientific is calling it quits on this iteration of its transcatheter valve, saying it will instead focus on Acurate neo. #TAVR #Recall
Lotus Edge TAVR Device Recalled and Discontinued Worldwide https://bit.ly/2IWhpKg
Boston Scientific is calling it quits on this iteration of its transcatheter valve, saying it will instead focus on Acurate neo. #TAVR #Recall
"This trial does not support the use of a more-potent P2Y12 antagonist for elective PCI." - Stephen Wiviott
Read more: Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS https://bit.ly/3kMVYs9
#PCI
Read more: Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS https://bit.ly/3kMVYs9
#PCI
PROSPECT II: A Prospective Natural History Study Using NIRS-IVUS Imaging in Patients with Acute Myocardial Infarction https://bit.ly/2UNMeTT
Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials https://bit.ly/3fkS1cZ
"The first question was whether this was really a safe thing to do." - Deepak Bhatt
"The first question was whether this was really a safe thing to do." - Deepak Bhatt
OCT and MRI Find an MI Cause in 85% of Women With MINOCA: HARP https://bit.ly/334oqQj
The findings support a role for OCT on top of CMR, already urged by guidelines. How outcomes might change remains unclear.
The findings support a role for OCT on top of CMR, already urged by guidelines. How outcomes might change remains unclear.
